Circassia Limited

Royaume‑Uni


 
Quantité totale PI 39
Quantité totale incluant filiales 52 (+ 13 pour les filiales)
Rang # Quantité totale PI 36 190
Note d'activité PI 1,3/5.0    4
Rang # Activité PI 239 501
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

9 2
0 1
18 6
3
 
Dernier brevet 2017 - Process for improving crystallinity
Premier brevet 1997 - Cryptic peptides and method for ...
Dernière marque 2022 - FENOLYTICS
Première marque 2014 - CIRCASSIA

Filiales

1 subsidiaries with IP (10 patents, 3 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2022 P/S Computer hardware and recorded software sold as a unit for diagnosing, monitoring, measuring, cal...
P/S Software; software and hardware for diagnosing, monitoring, measuring, calculating, analysing an...
2020 P/S Software and hardware for diagnosing, monitoring, measuring, calculating, analysing and displayi...
2017 Invention Process for improving crystallinity. This invention provides a process for increasing the crysta...
Invention Japanese pollen allergen peptides for preventing or treating allergy. A polypeptide or a pharmace...
2016 Invention Compositions with reduced dimer formation. The present invention relates to the use of a non-red...
Invention Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy. The present inv...
Invention Peptide with multiple epitopes. The present invention relates to peptides comprising multiple MH...
2015 Invention Pharmaceutical compositions. This invention provides a pharmaceutical composition comprising a e...
Invention Compositions with reduced dimer formation. The present invention relates to the use of a non-redu...
P/S Pharmaceutical and medicinal preparations and substances. Medical apparatus and instruments; inha...
Invention Process for making crystals. A process for preparing crystalline particles of an active principal...
Invention Vaccine peptide combinations against cat allergy. The present invention relates to compositions ...
P/S Pharmaceutical and veterinary preparations and substances; pharmaceutical and veterinary prepara...
P/S Pharmaceutical and veterinary preparations and substances; pharmaceutical and veterinary preparat...
Invention Peptides for vaccine against birch allergy. The present invention relates to compositions compri...
2014 P/S Pharmaceutical and veterinary preparations; vaccines. Surgical, medical and veterinary apparatus ...
P/S Pharmaceutical preparations for testing, diagnosis and treatment of allergies, autoimmune disease...
Invention Peptides for vaccine. The present invention relates to compositions comprising peptides for prev...
Invention T-cell antigen peptide from allergen for stimulation of il-10 production. A first or second poly...
Invention Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in ...
Invention Multi-component crystalline particles for inhalation therapy. Pharmaceutical Preparations Multi-...
Invention Peptide for vaccine. The present invention relates to compositions comprising peptides for preve...
2013 Invention Peptide with reduced dimer formation. The present invention relates to peptide which are formula...
Invention Japanese cedar peptide for preventing or treating allergy. A polypeptide which may be used for pr...
Invention Cladosporium peptides. Alternaria genus, have up to 30 amino acids in length and comprise: (I) th...
Invention Alternaria peptides. Pharmaceutical formulations, which may be used for preventing or treating a...
Invention Cladosporium peptides. Polypeptides which may be used for preventing or treating allergy to mould...
Invention Alternaria peptides. Pharmaceutical formulations,which may be used for preventing or treating all...
Invention Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy. T...
2012 Invention Pharmaceutical compositions. This invention provides a pharmaceutical composition comprising a eu...
2011 Invention Peptides for vaccine against birch allergy. The present invention relates to compositions compris...
Invention Peptides for vaccines against birch allergy. The present invention relates to compositions compri...
2010 Invention Barrier composition. The invention provides a process for increasing the crystallinity of at leas...
Invention T cell epitopes of the cyn d 1 allergen from bermuda grass pollen. The present invention relates ...
Invention Grass peptides for vaccine. The present invention relates to compositions comprising peptides for...
Invention Grass peptides for vaccine. The present invention relates to compositions comprising peptid...
2009 Invention Compositions with reduced dimer formation. The present invention relates to the use of a no...
Invention Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy. The present inve...
Invention T-cell antigen peptide from allergen for stimulation of il-10 production. wherein said disorder i...
Invention Ragweed peptides for vaccine. The present invention relates to compositions for preventing ...
Invention T-cell antigen peptide from allergen for stimulation of il-10 production. A first or second polyp...
Invention Process for improving crystallinity. This invention provides a process for increasing the crystal...
2008 Invention Peptide with reduced dimer formation. The present invention relates to peptides which are formula...
Invention Peptide with multiple epitopes. The present invention relates to peptides comprising multiple MHC...
Invention Peptide for vaccine. The present invention relates to compositions comprising peptides for preven...
Invention Process for making crystals. A process for preparing an emulsion or a dispersion comprising cryst...
Invention Vaccine peptide combinations against cat allergy. The present invention relates to compositions c...
Invention Prognostic assay for determining t cell response to hla antigens and use thereof in field of tiss...